News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Regulators Clear $50M Sale of Eli Lilly and Company Facility
August 26, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON -Federal antitrust regulators on Tuesday cleared Eli Lilly & Co.'s $50 million sale of a research facility to drug development services provider Covance Inc.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Real estate
MORE ON THIS TOPIC
Manufacturing
Tanabe pens deal to sell plants to Towa in post-buyout pivot
July 8, 2026
·
2 min read
·
Nick Paul Taylor
Immunology and inflammation
AstraZeneca bets up to $1.9B in respiratory disease collab with Sino Biopharmaceutical
July 8, 2026
·
2 min read
·
Tristan Manalac
Podcast
Vertex carries M&A uptick into H2, IPOs and VC raises also grow, FDA on pace despite turmoil
July 8, 2026
·
1 min read
·
Jef Akst
Artificial intelligence
Secretive AI drug hunter Xaira dips toe into dealmaking with hunt for partners
July 8, 2026
·
3 min read
·
Annalee Armstrong
